Bystronic Valuation
Is BYSZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BYSZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BYSZ (CHF346) is trading below our estimate of fair value (CHF2800.69)
Significantly Below Fair Value: BYSZ is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BYSZ?
Other financial metrics that can be useful for relative valuation.
| What is BYSZ's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CHF 711.36m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.5x |
| Enterprise Value/EBITDA | 19.2x |
| PEG Ratio | 7.6x |
Price to Sales Ratio vs Peers
How does BYSZ's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.6x | ||
MGAM Morgan Advanced Materials | 0.7x | 4.5% | UK£796.8m |
JDG Judges Scientific | 4.7x | 7.5% | UK£630.9m |
GDWN Goodwin | 2.9x | n/a | UK£552.7m |
LSC London Security | 2.1x | n/a | UK£465.9m |
BYSZ Bystronic | 0.9x | 1.5% | CHF 711.4m |
Price-To-Sales vs Peers: BYSZ is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (2.6x).
Price to Earnings Ratio vs Industry
How does BYSZ's PE Ratio compare vs other companies in the GB Machinery Industry?
Price-To-Sales vs Industry: BYSZ is good value based on its Price-To-Sales Ratio (0.9x) compared to the UK Machinery industry average (1.9x).
Price to Sales Ratio vs Fair Ratio
What is BYSZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.9x |
| Fair PS Ratio | 1.7x |
Price-To-Sales vs Fair Ratio: BYSZ is good value based on its Price-To-Sales Ratio (0.9x) compared to the estimated Fair Price-To-Sales Ratio (1.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CHF 346.00 | CHF 365.80 +5.7% | 18.6% | CHF 500.00 | CHF 320.00 | n/a | 5 |
| Sep ’25 | CHF 307.00 | CHF 393.50 +28.2% | 16.2% | CHF 500.00 | CHF 340.00 | n/a | 4 |
| Aug ’25 | CHF 314.50 | CHF 393.50 +25.1% | 16.2% | CHF 500.00 | CHF 340.00 | n/a | 4 |
| Jul ’25 | CHF 372.00 | CHF 472.25 +26.9% | 8.3% | CHF 520.00 | CHF 425.00 | n/a | 4 |
| Jun ’25 | CHF 447.50 | CHF 484.75 +8.3% | 8.1% | CHF 520.00 | CHF 425.00 | n/a | 4 |
| May ’25 | CHF 416.00 | CHF 484.75 +16.5% | 8.1% | CHF 520.00 | CHF 425.00 | n/a | 4 |
| Apr ’25 | CHF 476.75 | CHF 505.25 +6.0% | 6.2% | CHF 540.00 | CHF 455.00 | n/a | 4 |
| Mar ’25 | CHF 441.50 | CHF 535.25 +21.2% | 9.5% | CHF 610.00 | CHF 475.00 | n/a | 4 |
| Feb ’25 | CHF 435.00 | CHF 541.00 +24.4% | 8.9% | CHF 610.00 | CHF 475.00 | n/a | 4 |
| Jan ’25 | CHF 479.50 | CHF 540.50 +12.7% | 9.0% | CHF 610.00 | CHF 475.00 | n/a | 4 |
| Dec ’24 | CHF 483.00 | CHF 540.50 +11.9% | 9.0% | CHF 610.00 | CHF 475.00 | n/a | 4 |
| Nov ’24 | CHF 434.50 | CHF 540.50 +24.4% | 9.0% | CHF 610.00 | CHF 475.00 | n/a | 4 |
| Oct ’24 | CHF 573.00 | CHF 670.75 +17.1% | 8.1% | CHF 730.00 | CHF 615.00 | n/a | 4 |
| Sep ’24 | CHF 595.00 | CHF 715.80 +20.3% | 8.5% | CHF 810.00 | CHF 620.00 | CHF 307.00 | 5 |
| Aug ’24 | CHF 609.00 | CHF 715.80 +17.5% | 8.5% | CHF 810.00 | CHF 620.00 | CHF 314.50 | 5 |
| Jul ’24 | CHF 596.00 | CHF 727.80 +22.1% | 8.8% | CHF 810.00 | CHF 620.00 | CHF 372.00 | 5 |
| Jun ’24 | CHF 623.00 | CHF 733.80 +17.8% | 9.3% | CHF 810.00 | CHF 620.00 | CHF 447.50 | 5 |
| May ’24 | CHF 645.00 | CHF 733.80 +13.8% | 9.3% | CHF 810.00 | CHF 620.00 | CHF 416.00 | 5 |
| Apr ’24 | CHF 658.00 | CHF 741.80 +12.7% | 10.9% | CHF 850.00 | CHF 610.00 | CHF 476.75 | 5 |
| Mar ’24 | CHF 764.00 | CHF 734.20 -3.9% | 12.3% | CHF 850.00 | CHF 610.00 | CHF 441.50 | 5 |
| Feb ’24 | CHF 685.00 | CHF 718.00 +4.8% | 11.1% | CHF 850.00 | CHF 610.00 | CHF 435.00 | 5 |
| Jan ’24 | CHF 642.00 | CHF 726.00 +13.1% | 10.4% | CHF 850.00 | CHF 625.00 | CHF 479.50 | 5 |
| Dec ’23 | CHF 691.00 | CHF 777.00 +12.4% | 17.5% | CHF 985.00 | CHF 575.00 | CHF 483.00 | 5 |
| Nov ’23 | CHF 583.50 | CHF 777.00 +33.2% | 17.5% | CHF 985.00 | CHF 575.00 | CHF 434.50 | 5 |
| Oct ’23 | CHF 531.00 | CHF 888.00 +67.2% | 9.2% | CHF 990.00 | CHF 750.00 | CHF 573.00 | 5 |
| Sep ’23 | CHF 602.00 | CHF 978.00 +62.5% | 18.4% | CHF 1,300.00 | CHF 750.00 | CHF 595.00 | 5 |
Analyst Forecast: Target price is less than 20% higher than the current share price.